Summary
Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products comprise SBP-101 used for the treatment of pancreatic ductal adenocarcinoma, a common type of pancreatic cancer. Sun BioPharma also offers SBP-102 and SBP-103 for the treatment of pancreatic cancer. The company works in collaboration with various institutes, universities, cancer centers and other institutions for the development of drugs to treat pancreatic cancer. Sun BioPharma is headquartered in Waconia, Minnesota, the US.
Sun BioPharma Inc (SNBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sun BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sun BioPharma Raises USD1.5 Million in Venture Financing 10
Sun BioPharma Raises USD2 Million in Venture Financing 11
Sun Biopharma Raises US$3 Million In Venture Financing 12
Sun BioPharma Raises US$2.32 Million In Venture Financing 13
Sun BioPharma Raises US$0.55 Million In Seed Financing 14
Merger 15
Cimarron Medical Merges with Sun BioPharma in Reverse Merger Transaction 15
Licensing Agreements 16
Sun BioPharma Enters into Licensing Agreement with University of Florida Research Foundation 16
Equity Offering 17
Sun Biopharma Files Registration Statement to Raise up to USD19.37 Million in Public Offering of Shares 17
Sun BioPharma Plans to Raise Funds through Public Offering of Shares 18
Sun BioPharma Raises Funds in Private Placement of Shares and Warrants 19
Sun BioPharma Raises USD0.2 in Private Placement of Shares and Warrants 20
Sun BioPharma Raises USD2 Million in Private Placement of Shares and Warrants 21
Sun BioPharma Inc - Key Competitors 22
Sun BioPharma Inc - Key Employees 23
Sun BioPharma Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 10, 2017: Sun BioPharma reports financial results for the second quarter 2017 25
May 11, 2017: Sun BioPharma Reports First Quarter 2017 Results 26
Mar 30, 2017: Sun BioPharma Announces Financial Report of Year End December 2016 28
Mar 30, 2017: Sun BioPharma Q4 net loss increases 29
Nov 10, 2016: Sun BioPharma Reports Third Quarter 2016 Results and Provides Clinical Progress Update 30
Aug 11, 2016: Sun BioPharma Files Form 10-Q for Second Quarter 2016 and Provides Business Update 32
May 12, 2016: Sun BioPharma Provides Business Update and Reports Financial Results for Q1 2016 34
Mar 08, 2016: Sun BioPharma Reports Financial Results for Year Ended December 31, 2015 and Provides Business Update 35
Corporate Communications 37
Mar 03, 2016: Dr. Dalvir S. Gill Appointed to Sun BioPharma Board of Directors 37
Clinical Trials 38
Jan 06, 2016: Sun BioPharma Announces Dosing of First Patient in Phase 1 Clinical Study of SBP-101 for Pancreatic Cancer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List Of Tables
List of Tables
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sun BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sun BioPharma Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sun BioPharma Raises USD1.5 Million in Venture Financing 10
Sun BioPharma Raises USD2 Million in Venture Financing 11
Sun Biopharma Raises US$3 Million In Venture Financing 12
Sun BioPharma Raises US$2.32 Million In Venture Financing 13
Sun BioPharma Raises US$0.55 Million In Seed Financing 14
Cimarron Medical Merges with Sun BioPharma in Reverse Merger Transaction 15
Sun BioPharma Enters into Licensing Agreement with University of Florida Research Foundation 16
Sun Biopharma Files Registration Statement to Raise up to USD19.37 Million in Public Offering of Shares 17
Sun BioPharma Plans to Raise Funds through Public Offering of Shares 18
Sun BioPharma Raises Funds in Private Placement of Shares and Warrants 19
Sun BioPharma Raises USD0.2 in Private Placement of Shares and Warrants 20
Sun BioPharma Raises USD2 Million in Private Placement of Shares and Warrants 21
Sun BioPharma Inc, Key Competitors 22
Sun BioPharma Inc, Key Employees 23
Sun BioPharma Inc, Subsidiaries 24
List Of Figures
List of Figures
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sun BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
